195 related articles for article (PubMed ID: 34903034)
1. Bivalirudin Versus Heparin Monotherapy in ST-Segment-Elevation Myocardial Infarction.
James S; Koul S; Andersson J; Angerås O; Bhiladvala P; Calais F; Danielewicz M; Fröbert O; Grimfjärd P; Götberg M; Henareh L; Ioanes D; Jensen J; Linder R; Lindroos P; Omerovic E; Panayi G; Råmunddal T; Sarno G; Ulvenstam A; Völtz S; Wagner H; Wikström H; Östlund O; Erlinge D
Circ Cardiovasc Interv; 2021 Dec; 14(12):e008969. PubMed ID: 34903034
[TBL] [Abstract][Full Text] [Related]
2. Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction: A Prespecified Subgroup Analysis of the VALIDATE-SWEDEHEART Trial.
Wester A; Attar R; Mohammad MA; Isma N; James S; Omerovic E; Erlinge D; Koul S
Circ Cardiovasc Interv; 2020 Apr; 13(4):e008671. PubMed ID: 32216471
[TBL] [Abstract][Full Text] [Related]
3. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.
Erlinge D; Omerovic E; Fröbert O; Linder R; Danielewicz M; Hamid M; Swahn E; Henareh L; Wagner H; Hårdhammar P; Sjögren I; Stewart J; Grimfjärd P; Jensen J; Aasa M; Robertsson L; Lindroos P; Haupt J; Wikström H; Ulvenstam A; Bhiladvala P; Lindvall B; Lundin A; Tödt T; Ioanes D; Råmunddal T; Kellerth T; Zagozdzon L; Götberg M; Andersson J; Angerås O; Östlund O; Lagerqvist B; Held C; Wallentin L; Scherstén F; Eriksson P; Koul S; James S
N Engl J Med; 2017 Sep; 377(12):1132-1142. PubMed ID: 28844201
[TBL] [Abstract][Full Text] [Related]
4. Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; Omerovic E; Brugaletta S; Windecker S; Heg D; Jüni P;
Lancet; 2018 Sep; 392(10150):835-848. PubMed ID: 30153988
[TBL] [Abstract][Full Text] [Related]
5. Bivalirudin versus heparin monotherapy in non-ST-segment elevation myocardial infarction.
Erlinge D; Koul S; Omerovic E; Fröbert O; Linder R; Danielewicz M; Hamid M; Venetsanos D; Henareh L; Pettersson B; Wagner H; Grimfjärd P; Jensen J; Hofmann R; Ulvenstam A; Völz S; Petursson P; Östlund O; Sarno G; Wallentin L; Scherstén F; Eriksson P; James S
Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):492-501. PubMed ID: 30281320
[TBL] [Abstract][Full Text] [Related]
6. Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial).
Erlinge D; Koul S; Eriksson P; Scherstén F; Omerovic E; Linder R; Östlund OP; Wallentin L; Fröbert O; James S
Am Heart J; 2016 May; 175():36-46. PubMed ID: 27179722
[TBL] [Abstract][Full Text] [Related]
7. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
[TBL] [Abstract][Full Text] [Related]
8. Sex-related response to bivalirudin and unfractionated heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A subgroup analysis of the VALIDATE-SWEDEHEART trial.
Venetsanos D; Sederholm Lawesson S; Fröbert O; Omerovic E; Henareh L; Robertsson L; Linder R; Götberg M; James S; Alfredsson J; Erlinge D; Swahn E
Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):502-509. PubMed ID: 30351167
[TBL] [Abstract][Full Text] [Related]
9. Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.
Bikdeli B; Erlinge D; Valgimigli M; Kastrati A; Han Y; Steg PG; Stables RH; Mehran R; James SK; Frigoli E; Goldstein P; Li Y; Shahzad A; Schüpke S; Mehdipoor G; Chen S; Redfors B; Crowley A; Zhou Z; Stone GW
Circulation; 2023 Oct; 148(16):1207-1219. PubMed ID: 37746717
[TBL] [Abstract][Full Text] [Related]
10. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.
Stone GW; Mehran R; Goldstein P; Witzenbichler B; Van't Hof A; Guagliumi G; Hamm CW; Généreux P; Clemmensen P; Pocock SJ; Gersh BJ; Bernstein D; Deliargyris EN; Steg PG
J Am Coll Cardiol; 2015 Jan; 65(1):27-38. PubMed ID: 25572507
[TBL] [Abstract][Full Text] [Related]
11. One-Year Mortality for Bivalirudin vs Heparins Plus Optional Glycoprotein IIb/IIIa Inhibitor Treatment Started in the Ambulance for ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the EUROMAX Randomized Clinical Trial.
Fabris E; Kilic S; Van't Hof AWJ; Ten Berg J; Ayesta A; Zeymer U; Hamon M; Soulat L; Bernstein D; Anthopoulos P; Deliargyris EN; Steg PG
JAMA Cardiol; 2017 Jul; 2(7):791-796. PubMed ID: 28273285
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
Jovin IS; Shah RM; Patel DB; Rao SV; Baklanov DV; Moussa I; Kennedy KF; Secemsky EA; Yeh RW; Kontos MC; Vetrovec GW
JACC Cardiovasc Interv; 2017 Jun; 10(11):1102-1111. PubMed ID: 28527778
[TBL] [Abstract][Full Text] [Related]
13. One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.
Schulz S; Kastrati A; Ferenc M; Massberg S; Birkmeier KA; Laugwitz KL; Kufner S; Gick M; Dommasch M; Schühlen H; Schömig A; Berger PB; Mehilli J; Neumann FJ;
EuroIntervention; 2013 Aug; 9(4):430-6. PubMed ID: 23455033
[TBL] [Abstract][Full Text] [Related]
14. Radial versus femoral access in patients with acute coronary syndrome undergoing invasive management: A prespecified subgroup analysis from VALIDATE-SWEDEHEART.
Völz S; Angerås O; Koul S; Haraldsson I; Sarno G; Venetsanos D; Grimfärd P; Ulvenstam A; Hofmann R; Hamid M; Henareh L; Wagner H; Jensen J; Danielewicz M; Östlund O; Eriksson P; Scherstén F; Linder R; Råmunddal T; Pétursson P; Fröbert O; James S; Erlinge D; Omerovic E
Eur Heart J Acute Cardiovasc Care; 2019 Sep; 8(6):510-519. PubMed ID: 31237158
[TBL] [Abstract][Full Text] [Related]
15. Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.
Secemsky EA; Kirtane A; Bangalore S; Jovin IS; Shah RM; Ferro EG; Wimmer NJ; Roe M; Dai D; Mauri L; Yeh RW
JACC Cardiovasc Interv; 2016 Dec; 9(23):2376-2386. PubMed ID: 27838271
[TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors - a VALIDATE-SWEDEHEART Substudy.
Bergman S; Mohammad MA; James SK; Angerås O; Wagner H; Jensen J; Scherstén F; Fröbert O; Koul S; Erlinge D
J Am Heart Assoc; 2021 Sep; 10(18):e022984. PubMed ID: 34514849
[TBL] [Abstract][Full Text] [Related]
17. Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX) OCT study.
Garcia-Garcia HM; Adamo M; Soud M; Yacob O; Picchi A; Sardella G; Frigoli E; Limbruno U; Rigattieri S; Diletti R; Boccuzzi G; Zimarino M; Contarini M; Russo F; Calabrò P; Andò G; Varbella F; Garducci S; Palmieri C; Briguori C; Karagiannis A; Valgimigli M
Catheter Cardiovasc Interv; 2020 Nov; 96(6):1156-1171. PubMed ID: 31883294
[TBL] [Abstract][Full Text] [Related]
18. Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
Wang H; Li Y; Cong H; Ding S; Liu B; Li L; Chen Y; Jia S; Jing Q; Zhao X; Liu H; Liang Z; Li J; Bao D; Han Y
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1157-1165. PubMed ID: 27677411
[TBL] [Abstract][Full Text] [Related]
19. Heparin monotherapy or bivalirudin during percutaneous coronary intervention in patients with non-ST-segment-elevation acute coronary syndromes or stable ischemic heart disease: results from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.
Bangalore S; Pencina MJ; Kleiman NS; Cohen DJ
Circ Cardiovasc Interv; 2014 Jun; 7(3):365-73. PubMed ID: 24736878
[TBL] [Abstract][Full Text] [Related]
20. Bivalirudin for primary percutaneous coronary interventions: outcome assessment in the Ottawa STEMI registry.
Hibbert B; MacDougall A; Labinaz M; O'Brien ER; So DY; Dick A; Glover C; Froeschl M; Marquis JF; Wells GA; Blondeau M; Le May MR
Circ Cardiovasc Interv; 2012 Dec; 5(6):805-12. PubMed ID: 23149331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]